Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Our mission is to bring together people across diverse cultures and geographies to reach new heights of excellence in healthcare and foster a healthier and happier world.

We aim to be a leading healthcare company providing world-class products and services that drive healthier outcomes, making a positive impact on the lives of people.

Torrent Pharmaceuticals has been widely recognized and has won several awards in the international arena, such as the National Research Award for Drug Development, the National Innovation Award for Drug Development, the ICICI Lombard Outstanding Woman Entrepreneur Award, and more.